Pediatrix Medical Group (MD) Q3 2024 Earnings
MD·Reported November 1, 2024·Before market open
Pediatrix Medical Group reported Q3 2024 revenue of $511.2M, beat analyst consensus of $487.1M by $24.1M. Diluted EPS came in at $0.44, beat the $0.37 consensus by $0.07.
Revenue
$511.2Mbeat by $24.1M
Consensus: $487.1MDiluted EPS
$0.44beat by $0.07
Consensus: $0.37
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Pediatrix Medical Group's Q3 2024 earnings report.
Pediatrix Medical Group (MD) reported Q3 2024 earnings on November 1, 2024 before market open.
Pediatrix Medical Group reported revenue of $511.2M and diluted EPS of $0.44 for Q3 2024.
Revenue beat the consensus estimate of $487.1M by $24.1M. EPS beat the consensus estimate of $0.37 by $0.07.
You can read the 10-Q periodic report (0000950170-24-119796) directly on SEC EDGAR. The filing index links above go to sec.gov.